Vuity
Product Images NDC 0074-7098

8 FDA label images from Abbvie Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Vuity (NDC 0074-7098). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Abbvie Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Vuity 01)

Structural Formula (Vuity 01)
Chemical structure of the active ingredient in VUITY, showing a complex molecule featuring a five-membered lactone ring with attached substituents, including a methylated nitrogen-containing heterocycle and hydrochloride salt indicated by 'HCl.'*
FDA Label Image

Chart, Line Chartdescription Automatically Generated (Vuity 02)

Chart, Line Chartdescription Automatically Generated (Vuity 02)
This line graph compares the responder rate of VUITY versus a vehicle in gaining at least 3 lines improvement in mesopic DCNVA (%) over a 10-hour period. The x-axis represents time in hours, and the y-axis shows responder rate percentage. VUITY shows a peak responder rate near 42% at 1 hour that gradually declines, while the vehicle remains relatively flat, below 20%. The chart includes a data table listing responder rates and their differences with 95% confidence intervals at specific time points.*
FDA Label Image

Chart, Line Chartdescription Automatically Generated (Vuity 03)

Chart, Line Chartdescription Automatically Generated (Vuity 03)
A line graph displaying responder rates of at least 3-line gain in mesopic DCNVA (%) over time (hours) for VUITY and Vehicle groups. VUITY shows a rise peaking near hour 1 at about 37%, then gradually declines to about 12% by hour 10, while Vehicle remains relatively flat around 10% throughout. A table below the graph lists numerical responder rates and differences with 95% confidence intervals at multiple time points from hour 0 to hour 10.*
FDA Label Image

Allergan (Vuity 04)

FDA Label Image

Principal Display Panelndc 0074-7098-01vuity™ (pilocarpine Hci Ophthalmic Solution) 1.25%contains One 2.5 mL Bottlerx Onlysterilefor Topical Application In The Eye1 X 2.5 mLallergan™an Abbvie Company (Vuity 05)

Principal Display Panelndc 0074-7098-01vuity™ (pilocarpine Hci Ophthalmic Solution) 1.25%contains One 2.5 mL Bottlerx Onlysterilefor Topical Application In The Eye1 X 2.5 mLallergan™an Abbvie Company (Vuity 05)
Packaging label for VUITY (pilocarpine HCl ophthalmic solution) 1.25%, produced by AbbVie Inc. The label features dosage form as an ophthalmic solution in 2.5 mL unit size. The design includes the product name, active ingredient concentration, manufacturer and distributor information, lot number, expiration date, and storage instructions.*
FDA Label Image

Principal Display Panelinsert Text Ndc 0074-7098-03vuity™ (pilocarpine Hci Ophthalmic Solution) 1.25%contains One 2.5 mL Bottlerx Onlysterilefor Topical Application In The Eye3 X 2.5 mLallergan™an Abbvie Company (Vuity 06)

Principal Display Panelinsert Text Ndc 0074-7098-03vuity™ (pilocarpine Hci Ophthalmic Solution) 1.25%contains One 2.5 mL Bottlerx Onlysterilefor Topical Application In The Eye3 X 2.5 mLallergan™an Abbvie Company (Vuity 06)
VUITY (pilocarpine HCl ophthalmic solution) 1.25% carton labels shown laid flat. The packaging indicates a prescription ophthalmic solution supplied in 3 bottles each containing 2.5 mL. The labeler is AbbVie Inc., with distribution by Allergan. The label includes active ingredient details, usage instructions, storage information, and barcode.*
FDA Label Image

Principal Display Panelndc 0074-7098-04vuity™ (pilocarpine Hci Ophthalmic Solution) 1.25%rx Onlysterile2.5 mLfor Topical Application In The Eyeallergan™an Abbvie Company (Vuity 07)

Principal Display Panelndc 0074-7098-04vuity™ (pilocarpine Hci Ophthalmic Solution) 1.25%rx Onlysterile2.5 mLfor Topical Application In The Eyeallergan™an Abbvie Company (Vuity 07)
VUITY 1.25% pilocarpine hydrochloride ophthalmic solution in a 2.5 mL bottle. The label shows the product name, strength, and details including Rx only status, sterility, and usage instructions for topical application in the eye. Manufactured by AbbVie Inc. and distributed by Allergan, the label also lists active and inactive ingredients, storage conditions, and contains barcode and lot/expiration fields.*
FDA Label Image

Principal Display Panelndc 0074-7098-05professional Sample Not For Resalevuity™ (pilocarpine Hci Ophthalmic Solution) 1.25%rx Onlysterile1.5 mLfor Topical Application In The Eyeallergan™an Abbvie Company (Vuity 08)

Principal Display Panelndc 0074-7098-05professional Sample Not For Resalevuity™ (pilocarpine Hci Ophthalmic Solution) 1.25%rx Onlysterile1.5 mLfor Topical Application In The Eyeallergan™an Abbvie Company (Vuity 08)
VUITY (pilocarpine HCl ophthalmic solution) 1.25% 1.5 mL professional sample carton label. The label states the product is sterile, for topical application in the eye, Rx only, and distributed by Allergan. It includes storage instructions, active and inactive ingredients, dosage directions, and manufacturer information for AbbVie Inc. Packaging design features a teal and navy blue gradient background with the VUITY logo.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.